Health

The fight against lead: Progress made, but dangers remain

A review by a Rutgers Health expert shows that, despite decades of successful efforts to reduce lead exposure, the toxic metal still poses dangers in consumer products that warrant additional attention.

Medications

FDA approves Bimzelx for three new indications

The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active psoriatic arthritis (PsA), adults with active nonradiographic axial spondyloarthritis (nr-axSpA) with objective ...

page 9 from 20